Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001628280-24-035617
Filing Date
2024-08-07
Accepted
2024-08-07 16:10:23
Documents
68
Period of Report
2024-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q lyel-20240630.htm   iXBRL 10-Q 1374483
2 EX-10.1 lyel-20240630x10xqxexx101.htm EX-10.1 22154
3 EX-31.1 lyel-20240630x10qxexx311.htm EX-31.1 10649
4 EX-31.2 lyel-20240630x10qxexx312.htm EX-31.2 10619
5 EX-32.1 lyel-20240630x10qxexx321.htm EX-32.1 7494
11 lyel-20240630_g1.jpg GRAPHIC 199588
12 lyel-20240630_g2.jpg GRAPHIC 59667
13 lyel-20240630_g3.jpg GRAPHIC 42527
  Complete submission text file 0001628280-24-035617.txt   7386383

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT lyel-20240630.xsd EX-101.SCH 42634
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT lyel-20240630_cal.xml EX-101.CAL 52855
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT lyel-20240630_def.xml EX-101.DEF 223925
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT lyel-20240630_lab.xml EX-101.LAB 610433
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT lyel-20240630_pre.xml EX-101.PRE 426516
71 EXTRACTED XBRL INSTANCE DOCUMENT lyel-20240630_htm.xml XML 807399
Mailing Address 201 HASKINS WAY SOUTH SAN FRANCISCO CA 94080
Business Address 201 HASKINS WAY SOUTH SAN FRANCISCO CA 94080 650 695-0677
Lyell Immunopharma, Inc. (Filer) CIK: 0001806952 (see all company filings)

EIN.: 833006753 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-40502 | Film No.: 241183765
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)